SynBiotic Balance Sheet Health
Financial Health criteria checks 2/6
SynBiotic has a total shareholder equity of €22.8M and total debt of €4.8M, which brings its debt-to-equity ratio to 20.9%. Its total assets and total liabilities are €40.6M and €17.8M respectively.
Key information
20.9%
Debt to equity ratio
€4.77m
Debt
Interest coverage ratio | n/a |
Cash | €2.31m |
Equity | €22.79m |
Total liabilities | €17.83m |
Total assets | €40.62m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: SBX's short term assets (€8.0M) exceed its short term liabilities (€5.7M).
Long Term Liabilities: SBX's short term assets (€8.0M) do not cover its long term liabilities (€12.1M).
Debt to Equity History and Analysis
Debt Level: SBX's net debt to equity ratio (10.8%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if SBX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if SBX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SBX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.